Should the COVID Vaccine Turn a Big Profit for Big Pharma?

Powered by RedCircle

In the latest news on the coronavirus, Business Casual hosts Daniel Litwin and Tyler Kern analyze Pfizer CEO Albert Bourla’s recent statement about the ethics behind profiting off of a COVID vaccine.

As the government doles out taxpayer dollars to the private sector in the race for a cure, should the resulting vaccine still come at a price to Americans? Bourla is incredulous at the thought, saying “You need to be very fanatic and radical to say something like that right now.”

Whether private companies are getting aid from the government or not, the private sector has provided diagnostic and therapeutic solutions for COVID already. Business Casual explores both sides of the coin of American capitalism in this unprecedented ethical query, discussing…

  1. How “Operation Warp Speed,” has created costly government contracts with private health companies
  2. Why Pfizer has the potential to make over $13 billion in sales if they charge the public
  3. If the private sector finds a solution to COVID, are they accountable to the public’s taxpayer dollars that helped them create a vaccine?
  4. For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.Follow us on social media for the latest updates in B2B!Twitter – @MarketScale
    Facebook – facebook.com/marketscale
    LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More